Press Release November 29, 2021Codex DNA Announces Commercial Availability of Automated mRNA Synthesis Kit with Integrated Capping Technology for BioXp™ System 0 0 Share
Press Release November 29, 2021DaVita Clinical Research Study Indicates Effectiveness of mRNA COVID-19 Vaccines in Dialysis Patients 0 0 Share
Company Ticker News November 29, 2021Moderna (MRNA) Stock: $348 Price Target From Piper Sandler 0 0 Share
Company Ticker News November 22, 2021Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development 0 0 Share
Company Ticker News November 22, 2021Baidu Licenses Its Algorithm To Sanofi For mRNA Vaccine, Therapy Development 0 0 Share
Press Release November 18, 2021Moderna Announces First Participant Dosed in Phase 2/3 Study of its mRNA Respiratory Syncytial Virus (RSV) Vaccine 0 0 Share
Press Release November 18, 2021CureVac Publishes in Nature Preclinical Data of Second-Generation COVID-19 Candidate, CV2CoV, Demonstrating Comparable Antibody Levels to Licensed mRNA Vaccine 0 0 Share
Company Ticker News November 16, 2021AstraZeneca, Moderna Shares Early Cut Data For mRNA Candidate In Heart Failure 0 0 Share